tamsulosin has been researched along with Disease Models, Animal in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, H; Imai, S; Imai, Y; Kamo, I; Kohara, Y; Kuno, H; Nagabukuro, H; Okabe, Y; Saikawa, R; Sakauchi, N; Sato, A; Suzaki, T; Yoshida, M | 1 |
| da Silva Junior, ED; Gavioli, EC; Holanda, VAD; Oliveira, MC | 1 |
| Cudnoch-Jedrzejewska, A; Czarzasta, K; Fus, L; Gornicka, B; Jesion, A; Niemczyk, G; Radziszewski, P | 1 |
| Choi, BR; Karna, KK; Kim, HK; Lee, SW; Park, JK; So, I; Soni, KK | 1 |
| Ailawadi, G; Cullen, JM; Fashandi, A; Hassinger, T; Lu, G; Montgomery, WG; Salmon, MD; Sharma, AK; Spinosa, MD; Su, G; Upchurch, GR | 1 |
| Choi, EH; Gardella, A; Kefalov, VJ; Leinonen, H; Palczewski, K | 1 |
| Chen, S; Feng, X; Li, S; Shi, B; Zhang, Z; Zhu, Y | 1 |
| Shen, Z; Wang, X; Xia, L; Xu, T; Zhang, M; Zhang, X; Zhong, S; Zhu, Z | 1 |
| Chae, MR; Han, DH; Kang, SJ; Kim, CY; Kim, JJ; Lee, SW; Park, JK; Sung, HH | 1 |
| Choi, BR; Kim, HK; Lee, SW; Park, JK; So, I; Soni, KK; Zhang, LT | 1 |
| Yokoyama, O | 1 |
| Akino, H; Aoki, Y; Ito, H; Nagase, K; Tanase, K; Yokoyama, O | 1 |
| Matsumoto, S; Ohtake, A; Okutsu, H; Sasamata, M; Sato, S; Suzuki, M; Uemura, H | 1 |
| Endo, K; Funahashi, Y; Gotoh, M; Hattori, R; Kato, M; Matsukawa, Y; Mine, S; Mizuno, H; Yamamoto, T | 1 |
| Akiyama, K; Kobayashi, M; Tatemichi, S; Uruno, T; Yamazaki, Y; Yokoyama, O | 1 |
| Akino, H; Aoki, Y; Ito, H; Miwa, Y; Oyama, N; Yokoyama, O | 1 |
| Kitteringham, NR; Macdonald, I; Park, BK; Randle, LE; Sathish, JG; Williams, DP | 1 |
| Chang, DF; Lluel, P; Palea, S; Regnier, A; Rekik, M | 1 |
18 other study(ies) available for tamsulosin and Disease Models, Animal
| Article | Year |
|---|---|
Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related G
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Animals; Chemistry Techniques, Synthetic; Cystitis; Disease Models, Animal; Drug Discovery; Drug Evaluation, Preclinical; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Imines; Molecular Docking Simulation; Mutagenesis, Site-Directed; Niacinamide; Rats; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive | 2016 |
Tamsulosin facilitates depressive-like behaviors in mice: Involvement of endogenous glucocorticoids.
Topics: Adaptation, Psychological; Adrenergic alpha-1 Receptor Antagonists; Aminoglutethimide; Animals; Aromatase Inhibitors; Behavior, Animal; Depression; Disease Models, Animal; Hormone Antagonists; Hypothalamo-Hypophyseal System; Mice; Mifepristone; Receptors, Glucocorticoid; Tamsulosin | 2022 |
Expression of Toll-Like Receptors in the Animal Model of Bladder Outlet Obstruction.
Topics: Adrenergic alpha-Agonists; Animals; Body Weight; Disease Models, Animal; Inflammation; Interleukin-18; Interleukin-6; Male; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Tamsulosin; Toll-Like Receptor 4; Toll-Like Receptor 9; Urinary Bladder; Urinary Bladder Neck Obstruction | 2020 |
Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model.
Topics: Administration, Oral; Animals; Benzofurans; Disease Models, Animal; Drug Therapy, Combination; Finasteride; Indoles; Male; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Testosterone | 2018 |
Tamsulosin attenuates abdominal aortic aneurysm growth.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Pressure; Cytokines; Disease Models, Animal; Down-Regulation; Drug Evaluation, Preclinical; Elastin; Humans; Male; Mice; Mice, Inbred C57BL; Pancreatic Elastase; Tamsulosin; Treatment Outcome | 2018 |
A Mixture of U.S. Food and Drug Administration-Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Arrestins; Bromocriptine; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 1; Light; Metoprolol; Mice; Night Blindness; Tamsulosin; Transducin; United States; United States Food and Drug Administration | 2019 |
Changes in alpha1-adrenoceptor and NGF/proNGF pathway: a possible mechanism in diabetic urethral dysfunction.
Topics: Adaptor Proteins, Vesicular Transport; Adrenergic alpha-1 Receptor Antagonists; Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Nerve Growth Factor; Perfusion; Pressure; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Nerve Growth Factor; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethra | 2014 |
Histopathological classification criteria of rat model of chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Autoimmune Diseases; Disease Models, Animal; Epithelium; Male; Prostate; Prostatitis; Random Allocation; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin | 2015 |
New Methodology for Investigating Ejaculation Dysfunction: Measuring Intraluminal Seminal Vesicle Pressure in Rats with a Telemetric Device.
Topics: Animals; Apomorphine; Disease Models, Animal; Ejaculation; Indoles; Male; Penis; Pressure; Rats; Rats, Sprague-Dawley; Seminal Vesicles; Sexual Behavior; Sulfonamides; Tamsulosin; Telemetry; Urological Agents | 2015 |
Effect of 4-chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2-b]indole-1-carboxylic acid on the intraurethral pressure in a rat model of benign prostatic hyperplasia.
Topics: Animals; Benzofurans; Disease Models, Animal; Electric Stimulation; Estradiol; Humans; Indoles; Male; Pressure; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethra | 2016 |
Pharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Afferent Pathways; Animals; Benzhydryl Compounds; Brain; Cerebral Infarction; Cresols; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Excitatory Amino Acid Antagonists; Muscarinic Antagonists; Muscle Contraction; Nerve Fibers, Unmyelinated; Neuronal Plasticity; Phenylpropanolamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; RNA, Messenger; Sulfonamides; Tamsulosin; Time Factors; Tolterodine Tartrate; Transcription, Genetic; Urinary Bladder; Urinary Bladder, Overactive | 2010 |
Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Analysis of Variance; Animals; Disease Models, Animal; Diterpenes; Drug Therapy, Combination; Female; Infarction, Middle Cerebral Artery; Muscarinic Antagonists; Muscle Contraction; Organ Size; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder, Overactive | 2011 |
Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention/emptying induced bladder overactivity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Disease Models, Animal; Female; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sulfonamides; Tamsulosin; Urinary Bladder; Urinary Bladder, Overactive | 2011 |
Effect of tamsulosin on bladder microcirculation in rat model of bladder outlet obstruction using pencil lens charge-coupled device microscopy system.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Capillaries; Chronic Disease; Disease Models, Animal; Female; Ischemia; Microcirculation; Microscopy; Rats; Rats, Wistar; Regional Blood Flow; Sulfonamides; Tamsulosin; Urinary Bladder; Urinary Bladder Neck Obstruction | 2013 |
A selective alpha1A-adrenoceptor antagonist inhibits detrusor overactivity in a rat model of benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Female; Indoles; Male; Prazosin; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urinary Incontinence | 2006 |
Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
Topics: Administration, Intravesical; Administration, Topical; Adrenergic alpha-Antagonists; Animals; Atropine; Benzilates; Calcium Channel Blockers; Cholinergic Antagonists; Dinoprostone; Disease Models, Animal; Female; Injections, Intra-Arterial; Muscarinic Antagonists; Muscle Contraction; omega-Conotoxins; Oxytocics; Pressure; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin; Treatment Outcome; Urethra; Urinary Bladder; Urinary Bladder, Overactive; Verapamil | 2007 |
alpha(1)-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice.
Topics: Acetaminophen; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Catecholamines; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Doxazosin; Erythrocytes; Gene Expression Regulation, Enzymologic; Glutamate-Cysteine Ligase; Glutathione; Heme Oxygenase-1; Liver; Liver Circulation; Liver Diseases; Male; Membrane Proteins; Mice; Prazosin; Protein Binding; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Time Factors; Transaminases | 2008 |
Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Intraoperative Complications; Iris; Iris Diseases; Male; Muscle, Smooth; Phenylephrine; Prostate; Quinazolines; Rabbits; Sulfonamides; Sympathomimetics; Syndrome; Tamsulosin | 2008 |